EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.85 | Atherosclerosis |
20479009 |
Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. |
causal interaction ongoing research unassigned |
4 4 0 |
2.3.1.85 | Breast Neoplasms |
10667561 |
Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. |
causal interaction therapeutic application unassigned |
3 1 0 |
2.3.1.85 | Carcinoma, Hepatocellular |
7567999 |
Human fatty acid synthase: properties and molecular cloning. |
ongoing research unassigned |
4 0 |
2.3.1.85 | Chronic Periodontitis |
29400320 |
Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK). |
causal interaction therapeutic application unassigned |
1 1 0 |
2.3.1.85 | Dehydration |
17804795 |
The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis. |
ongoing research therapeutic application unassigned |
2 1 0 |
2.3.1.85 | Dehydration |
25897434 |
Covalent modification of the Mycobacterium tuberculosis FAS-II dehydratase by Isoxyl and Thiacetazone. |
causal interaction therapeutic application unassigned |
4 1 0 |
2.3.1.85 | Dehydration |
31775512 |
Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in Mycobacterium tuberculosis. |
causal interaction therapeutic application unassigned |
4 3 0 |
2.3.1.85 | fatty-acid synthase system deficiency |
20479009 |
Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. |
causal interaction ongoing research unassigned |
4 4 0 |
2.3.1.85 | Infections |
18172196 |
A combined transcriptome and proteome survey of malaria parasite liver stages. |
causal interaction therapeutic application unassigned |
2 3 0 |
2.3.1.85 | Infections |
25677657 |
Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). |
causal interaction therapeutic application unassigned |
3 4 0 |